Amazon Biotech, Inc. Announces Patent Approval for a Unique Formulation and Method of Treating HIV Infection (SYS-CON Media)
Amazon Biotech, Inc. Announces Patent Approval for a Unique Formulation and Method of Treating HIV Infection (SYS-CON Media)
Amazon Biotech, Inc. (OTCBB: AMZB) (FRANKFURT: B2D.F) today announced that it has a Notice of Allowance from the UnitedStates Patent and Trademark Office, advising that Amazon’s application forpatent protection of its investigative drug named AMZ0026 has beenapproved.